Gf Fund Management Co. Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,186 shares of ARWR stock, worth $44,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,186
Previous 2,613
21.93%
Holding current value
$44,253
Previous $49.1 Million
17.37%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
301Shares Held
96MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$218 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$169 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$154 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$83.6 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$72.7 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.47B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...